DEA Proposes Even Higher 2023 Production Quotas For Psychedelics Like MDMA And Psilocyn

DEA Proposes Even Higher 2023 Production Quotas For Psychedelics Like MDMA And Psilocyn
MJ moment

The Drug Enforcement Administration (DEA) has released its final 2023 production quotas for drugs to be used in research—and the agency is now calling for even more manufacturing of psychedelic compounds like MDMA, psilocyn and 5-MeO-DMT than the existing significant increases it had initially proposed for next year. DEA first listed the target 2023 production goals for controlled substances last month, with significant increases in the proposed quota for drugs like marijuana, psilocyn, LSD and mescaline compared to 2022. Now, following a public comment period, it’s expanding certain quotas even further. For psilocyn, for example, the agency originally set its 2023 goal at 8,000 grams, which already represented a doubling of the 2022 amount. DEA now says it’s aiming for 12,000 grams of the psychedelic compound, which is found in so-called magic mushrooms. It further wants to increase the quotas for 5-MeO-DMT from an initial 6,000 to 11,000 and MDMA from 8,200 to 12,000 grams. The most significant changes in the final 2023 production numbers were for MDA, which jumped from 200 to 12,000 grams and 2-CB, which went from 25 to 5,100 grams. “DEA is committed to ensuring an adequate and uninterrupted supply of controlled substances in order to meet the estimated legitimate medical, scientific, research, and industrial needs of the U.S., for lawful export requirements, and for the establishment and maintenance of reserve stocks,” the agency said several times in a notice set to be published in the Federal Register on Friday. For marijuana, DEA also boosted the production quota in the initial 2023 proposal, saying it wants to see 6.7 million grams (or 14,770 pounds) of cannabis grown next year to meet those medical and scientific demands. That numbers is staying the same in the new final filing. The agency’s…

Excerpt only …
READ MORE BELOW
Source : DEA Proposes Even Higher 2023 Production Quotas For Psychedelics Like MDMA And Psilocyn

reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.